Annex
United Kingdom
Regulation (EEC) No 2377/90 is amended as follows:
- A..
Annex I is modified as follows:
- 1..
Anti-infectious agents
- 1.2.
Antibiotics
- 1.2.4.
Macrolides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions ‘1.2.4.3.
Spiramycin
Sum of spiramycin and neospiramycin Bovine 300 μg/kg Liver, kidney, fat 200 μg/kg Muscle 200 μg/kg Milk Chicken 400 μg/kg Liver 300 μg/kg Fat + skin 200 μg/kg Muscle’
- 1.2.4.
- 1.2.
- 2..
Antiparasitic agents
- 2.2.
Agents acting against ectoparasites
- 2.2.3.
Organophosphates
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions ‘2.2.3.1.
Diazinon
Diazinon Bovine, ovine, caprine, 700 μg/kg porcine Fat 20 μg/kg Kidney, liver, muscle Bovine, ovine, caprine 20 μg/kg Milk’
- 2.2.3.
- 2.2.
- 3..
Agents acting on the nervous system
- 3.2.
Agents acting on the autonomic nervous system
- 3.2.1.
Anti-adrenergics
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions ‘3.2.1.1.
Carazolol
Carazolol Porcine 25 μg/kg Liver, kidney 5 μg/kg Muscle, fat, + skin’
- 3.2.1.
- 3.2.
- 1..
- B..
In Annex II the following headings are added:
- 1..
Inorganic chemicals
Pharmacologically Active Substance(s) Animal Species Other provisions ‘1.6.
Hydrochloric acid
All food producing species For use as excipient 1.7.
Sodium dichloroisocyanurate
Bovine, ovine, caprine For topical use only’ - 2..
Organic chemicals
Pharmacologically Active Substance(s) Animal Species Other provisions ‘2.20.
Lecirelin
Bovine, equidae, rabbit 2.21.
Dinoprost tromethamine
All mammalian species 2.22.
Malic acid
All food producing species For use as excipient 2.23.
L-tartaric acid and its mono- and di-basic salt of sodium, potassium and calcium
Al food producing species For use as excipient 2.24.
Benzylalcohol
All food producing species For use as excipient 2.25.
Ethanol
All food producing species For use as excipient 2.26.
N-butanol
All food producing species For use as excipient’
- 1..
- C..
Annex III is modified as follows:
- 1..
Anti-infectious agents
- 1.2.
Antibiotics
- 1.2.2.
Macrolides
Pharmacologically Active substance(s) Marker Residue Animal Species MRLs Target Tissues Other provisions ‘1.2.2.1.
Spiramycin
Spiramycin Porcine 600 μg/kg Liver Provisional MRLs expire on 1 July 1997
MRLs apply to all microbiological active residues expressed as Spiramycin-equivalent
300 μg/kg Kidney, muscle 200 μg/kg Fat 1.2.2.2.
Tylosin
Tylosin Bovine, Porcine, Poultry 100 μg/kg Muscle, liver, kidney Provisional MRLs expire on 1 July 1997 Bovine 50 μg/kg Milk 1.2.2.3.
Erythromycin
Erythromycin Bovine, ovine, porcine, poultry 400 μg/kg Liver, kidney, muscle, fat Provisional MRLs expire on 1 June 2000
MRLs apply to all microbiological active residues expressed as Erythromycin-equivalent’
Bovine, ovine 40 μg/kg Milk Poultry 200 μg/kg Eggs - 1.2.4.
Quinolones
Pharmacologically Active substance(s) Marker Residue Animal Species MRLs Target Tissues Other provisions ‘1.2.4.1.
Danofloxacin
Danofloxacin Bovine 900 μg/kg Liver Provisional MRLs expire on 1 July 1997’ 500 μg/kg Kidney 300 μg/kg Muscle 200 μg/kg Fat Chicken 1 200 μg/kg Liver, kidney 600 μg/kg Fat + skin 300 μg/kg Muscle
- 1.2.2.
- 1.2.
- 1..
- D..
Annex IV is modified as follows:
List of pharmacologically active substances for which no maximum residue limits can be fixed
‘5.
Furazolidon’